Clinical Trial Update: A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis [Phase 3]

View source ↗

Summary

Phase 3 long-term follow-up study of botulinum toxin type A for overactive bladder due to spinal cord injury or multiple sclerosis completed with posted results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Allergan | Conditions: Overactive Bladder | Phase 3 | Status: COMPLETED | Results posted: 2014-06-13